This report aims to provide a comprehensive presentation of the global market for Preclinical Drug Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical Drug Development Services. This report contains market size and forecasts of Preclinical Drug Development Services in global, including the following market information:
Global Preclinical Drug Development Services Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Preclinical Drug Development Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
API Preparation Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Preclinical Drug Development Services include Wuxi AppTec, Labcorp, Charles River, Eurofins Scientific, PPD, Inc., ICON Plc., Pharmaron, Inotiv and ChemPartner, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Preclinical Drug Development Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Preclinical Drug Development Services Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Preclinical Drug Development Services Market Segment Percentages, by Type, 2022 (%)
API Preparation
Formulation Studies
Safety Studies
ADME Stuies
Global Preclinical Drug Development Services Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Preclinical Drug Development Services Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical
Bio-pharmaceutical
Global Preclinical Drug Development Services Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Preclinical Drug Development Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Preclinical Drug Development Services revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Preclinical Drug Development Services revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Wuxi AppTec
Labcorp
Charles River
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Noble Life Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Preclinical Drug Development Services, market overview.
Chapter 2: Global Preclinical Drug Development Services market size in revenue.
Chapter 3: Detailed analysis of Preclinical Drug Development Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Preclinical Drug Development Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Preclinical Drug Development Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Preclinical Drug Development Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Preclinical Drug Development Services Overall Market Size
2.1 Global Preclinical Drug Development Services Market Size: 2022 VS 2029
2.2 Global Preclinical Drug Development Services Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Preclinical Drug Development Services Players in Global Market
3.2 Top Global Preclinical Drug Development Services Companies Ranked by Revenue
3.3 Global Preclinical Drug Development Services Revenue by Companies
3.4 Top 3 and Top 5 Preclinical Drug Development Services Companies in Global Market, by Revenue in 2022
3.5 Global Companies Preclinical Drug Development Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Preclinical Drug Development Services Players in Global Market
3.6.1 List of Global Tier 1 Preclinical Drug Development Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Preclinical Drug Development Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Preclinical Drug Development Services Market Size Markets, 2022 & 2029
4.1.2 API Preparation
4.1.3 Formulation Studies
4.1.4 Safety Studies
4.1.5 ADME Stuies
4.2 By Type - Global Preclinical Drug Development Services Revenue & Forecasts
4.2.1 By Type - Global Preclinical Drug Development Services Revenue, 2018-2023
4.2.2 By Type - Global Preclinical Drug Development Services Revenue, 2024-2029
4.2.3 By Type - Global Preclinical Drug Development Services Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Preclinical Drug Development Services Market Size, 2022 & 2029
5.1.2 Pharmaceutical
5.1.3 Bio-pharmaceutical
5.2 By Application - Global Preclinical Drug Development Services Revenue & Forecasts
5.2.1 By Application - Global Preclinical Drug Development Services Revenue, 2018-2023
5.2.2 By Application - Global Preclinical Drug Development Services Revenue, 2024-2029
5.2.3 By Application - Global Preclinical Drug Development Services Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Preclinical Drug Development Services Market Size, 2022 & 2029
6.2 By Region - Global Preclinical Drug Development Services Revenue & Forecasts
6.2.1 By Region - Global Preclinical Drug Development Services Revenue, 2018-2023
6.2.2 By Region - Global Preclinical Drug Development Services Revenue, 2024-2029
6.2.3 By Region - Global Preclinical Drug Development Services Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Preclinical Drug Development Services Revenue, 2018-2029
6.3.2 US Preclinical Drug Development Services Market Size, 2018-2029
6.3.3 Canada Preclinical Drug Development Services Market Size, 2018-2029
6.3.4 Mexico Preclinical Drug Development Services Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Preclinical Drug Development Services Revenue, 2018-2029
6.4.2 Germany Preclinical Drug Development Services Market Size, 2018-2029
6.4.3 France Preclinical Drug Development Services Market Size, 2018-2029
6.4.4 U.K. Preclinical Drug Development Services Market Size, 2018-2029
6.4.5 Italy Preclinical Drug Development Services Market Size, 2018-2029
6.4.6 Russia Preclinical Drug Development Services Market Size, 2018-2029
6.4.7 Nordic Countries Preclinical Drug Development Services Market Size, 2018-2029
6.4.8 Benelux Preclinical Drug Development Services Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Preclinical Drug Development Services Revenue, 2018-2029
6.5.2 China Preclinical Drug Development Services Market Size, 2018-2029
6.5.3 Japan Preclinical Drug Development Services Market Size, 2018-2029
6.5.4 South Korea Preclinical Drug Development Services Market Size, 2018-2029
6.5.5 Southeast Asia Preclinical Drug Development Services Market Size, 2018-2029
6.5.6 India Preclinical Drug Development Services Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Preclinical Drug Development Services Revenue, 2018-2029
6.6.2 Brazil Preclinical Drug Development Services Market Size, 2018-2029
6.6.3 Argentina Preclinical Drug Development Services Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Preclinical Drug Development Services Revenue, 2018-2029
6.7.2 Turkey Preclinical Drug Development Services Market Size, 2018-2029
6.7.3 Israel Preclinical Drug Development Services Market Size, 2018-2029
6.7.4 Saudi Arabia Preclinical Drug Development Services Market Size, 2018-2029
6.7.5 UAE Preclinical Drug Development Services Market Size, 2018-2029
7 Preclinical Drug Development Services Companies Profiles
7.1 Wuxi AppTec
7.1.1 Wuxi AppTec Company Summary
7.1.2 Wuxi AppTec Business Overview
7.1.3 Wuxi AppTec Preclinical Drug Development Services Major Product Offerings
7.1.4 Wuxi AppTec Preclinical Drug Development Services Revenue in Global Market (2018-2023)
7.1.5 Wuxi AppTec Key News & Latest Developments
7.2 Labcorp
7.2.1 Labcorp Company Summary
7.2.2 Labcorp Business Overview
7.2.3 Labcorp Preclinical Drug Development Services Major Product Offerings
7.2.4 Labcorp Preclinical Drug Development Services Revenue in Global Market (2018-2023)
7.2.5 Labcorp Key News & Latest Developments
7.3 Charles River
7.3.1 Charles River Company Summary
7.3.2 Charles River Business Overview
7.3.3 Charles River Preclinical Drug Development Services Major Product Offerings
7.3.4 Charles River Preclinical Drug Development Services Revenue in Global Market (2018-2023)
7.3.5 Charles River Key News & Latest Developments
7.4 Eurofins Scientific
7.4.1 Eurofins Scientific Company Summary
7.4.2 Eurofins Scientific Business Overview
7.4.3 Eurofins Scientific Preclinical Drug Development Services Major Product Offerings
7.4.4 Eurofins Scientific Preclinical Drug Development Services Revenue in Global Market (2018-2023)
7.4.5 Eurofins Scientific Key News & Latest Developments
7.5 PPD, Inc.
7.5.1 PPD, Inc. Company Summary
7.5.2 PPD, Inc. Business Overview
7.5.3 PPD, Inc. Preclinical Drug Development Services Major Product Offerings
7.5.4 PPD, Inc. Preclinical Drug Development Services Revenue in Global Market (2018-2023)
7.5.5 PPD, Inc. Key News & Latest Developments
7.6 ICON Plc.
7.6.1 ICON Plc. Company Summary
7.6.2 ICON Plc. Business Overview
7.6.3 ICON Plc. Preclinical Drug Development Services Major Product Offerings
7.6.4 ICON Plc. Preclinical Drug Development Services Revenue in Global Market (2018-2023)
7.6.5 ICON Plc. Key News & Latest Developments
7.7 Pharmaron
7.7.1 Pharmaron Company Summary
7.7.2 Pharmaron Business Overview
7.7.3 Pharmaron Preclinical Drug Development Services Major Product Offerings
7.7.4 Pharmaron Preclinical Drug Development Services Revenue in Global Market (2018-2023)
7.7.5 Pharmaron Key News & Latest Developments
7.8 Inotiv
7.8.1 Inotiv Company Summary
7.8.2 Inotiv Business Overview
7.8.3 Inotiv Preclinical Drug Development Services Major Product Offerings
7.8.4 Inotiv Preclinical Drug Development Services Revenue in Global Market (2018-2023)
7.8.5 Inotiv Key News & Latest Developments
7.9 ChemPartner
7.9.1 ChemPartner Company Summary
7.9.2 ChemPartner Business Overview
7.9.3 ChemPartner Preclinical Drug Development Services Major Product Offerings
7.9.4 ChemPartner Preclinical Drug Development Services Revenue in Global Market (2018-2023)
7.9.5 ChemPartner Key News & Latest Developments
7.10 JOINN Lab
7.10.1 JOINN Lab Company Summary
7.10.2 JOINN Lab Business Overview
7.10.3 JOINN Lab Preclinical Drug Development Services Major Product Offerings
7.10.4 JOINN Lab Preclinical Drug Development Services Revenue in Global Market (2018-2023)
7.10.5 JOINN Lab Key News & Latest Developments
7.11 EVOTEC
7.11.1 EVOTEC Company Summary
7.11.2 EVOTEC Business Overview
7.11.3 EVOTEC Preclinical Drug Development Services Major Product Offerings
7.11.4 EVOTEC Preclinical Drug Development Services Revenue in Global Market (2018-2023)
7.11.5 EVOTEC Key News & Latest Developments
7.12 Medicilon
7.12.1 Medicilon Company Summary
7.12.2 Medicilon Business Overview
7.12.3 Medicilon Preclinical Drug Development Services Major Product Offerings
7.12.4 Medicilon Preclinical Drug Development Services Revenue in Global Market (2018-2023)
7.12.5 Medicilon Key News & Latest Developments
7.13 Noble Life Sciences
7.13.1 Noble Life Sciences Company Summary
7.13.2 Noble Life Sciences Business Overview
7.13.3 Noble Life Sciences Preclinical Drug Development Services Major Product Offerings
7.13.4 Noble Life Sciences Preclinical Drug Development Services Revenue in Global Market (2018-2023)
7.13.5 Noble Life Sciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Preclinical Drug Development Services Market Opportunities & Trends in Global Market
Table 2. Preclinical Drug Development Services Market Drivers in Global Market
Table 3. Preclinical Drug Development Services Market Restraints in Global Market
Table 4. Key Players of Preclinical Drug Development Services in Global Market
Table 5. Top Preclinical Drug Development Services Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Preclinical Drug Development Services Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Preclinical Drug Development Services Revenue Share by Companies, 2018-2023
Table 8. Global Companies Preclinical Drug Development Services Product Type
Table 9. List of Global Tier 1 Preclinical Drug Development Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Preclinical Drug Development Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Preclinical Drug Development Services Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Preclinical Drug Development Services Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Preclinical Drug Development Services Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Preclinical Drug Development Services Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Preclinical Drug Development Services Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Preclinical Drug Development Services Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Preclinical Drug Development Services Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Preclinical Drug Development Services Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Preclinical Drug Development Services Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Preclinical Drug Development Services Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Preclinical Drug Development Services Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Preclinical Drug Development Services Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Preclinical Drug Development Services Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Preclinical Drug Development Services Revenue, (US$, Mn), 2024-2029
Table 30. Wuxi AppTec Company Summary
Table 31. Wuxi AppTec Preclinical Drug Development Services Product Offerings
Table 32. Wuxi AppTec Preclinical Drug Development Services Revenue (US$, Mn) & (2018-2023)
Table 33. Wuxi AppTec Key News & Latest Developments
Table 34. Labcorp Company Summary
Table 35. Labcorp Preclinical Drug Development Services Product Offerings
Table 36. Labcorp Preclinical Drug Development Services Revenue (US$, Mn) & (2018-2023)
Table 37. Labcorp Key News & Latest Developments
Table 38. Charles River Company Summary
Table 39. Charles River Preclinical Drug Development Services Product Offerings
Table 40. Charles River Preclinical Drug Development Services Revenue (US$, Mn) & (2018-2023)
Table 41. Charles River Key News & Latest Developments
Table 42. Eurofins Scientific Company Summary
Table 43. Eurofins Scientific Preclinical Drug Development Services Product Offerings
Table 44. Eurofins Scientific Preclinical Drug Development Services Revenue (US$, Mn) & (2018-2023)
Table 45. Eurofins Scientific Key News & Latest Developments
Table 46. PPD, Inc. Company Summary
Table 47. PPD, Inc. Preclinical Drug Development Services Product Offerings
Table 48. PPD, Inc. Preclinical Drug Development Services Revenue (US$, Mn) & (2018-2023)
Table 49. PPD, Inc. Key News & Latest Developments
Table 50. ICON Plc. Company Summary
Table 51. ICON Plc. Preclinical Drug Development Services Product Offerings
Table 52. ICON Plc. Preclinical Drug Development Services Revenue (US$, Mn) & (2018-2023)
Table 53. ICON Plc. Key News & Latest Developments
Table 54. Pharmaron Company Summary
Table 55. Pharmaron Preclinical Drug Development Services Product Offerings
Table 56. Pharmaron Preclinical Drug Development Services Revenue (US$, Mn) & (2018-2023)
Table 57. Pharmaron Key News & Latest Developments
Table 58. Inotiv Company Summary
Table 59. Inotiv Preclinical Drug Development Services Product Offerings
Table 60. Inotiv Preclinical Drug Development Services Revenue (US$, Mn) & (2018-2023)
Table 61. Inotiv Key News & Latest Developments
Table 62. ChemPartner Company Summary
Table 63. ChemPartner Preclinical Drug Development Services Product Offerings
Table 64. ChemPartner Preclinical Drug Development Services Revenue (US$, Mn) & (2018-2023)
Table 65. ChemPartner Key News & Latest Developments
Table 66. JOINN Lab Company Summary
Table 67. JOINN Lab Preclinical Drug Development Services Product Offerings
Table 68. JOINN Lab Preclinical Drug Development Services Revenue (US$, Mn) & (2018-2023)
Table 69. JOINN Lab Key News & Latest Developments
Table 70. EVOTEC Company Summary
Table 71. EVOTEC Preclinical Drug Development Services Product Offerings
Table 72. EVOTEC Preclinical Drug Development Services Revenue (US$, Mn) & (2018-2023)
Table 73. EVOTEC Key News & Latest Developments
Table 74. Medicilon Company Summary
Table 75. Medicilon Preclinical Drug Development Services Product Offerings
Table 76. Medicilon Preclinical Drug Development Services Revenue (US$, Mn) & (2018-2023)
Table 77. Medicilon Key News & Latest Developments
Table 78. Noble Life Sciences Company Summary
Table 79. Noble Life Sciences Preclinical Drug Development Services Product Offerings
Table 80. Noble Life Sciences Preclinical Drug Development Services Revenue (US$, Mn) & (2018-2023)
Table 81. Noble Life Sciences Key News & Latest Developments
List of Figures
Figure 1. Preclinical Drug Development Services Segment by Type in 2022
Figure 2. Preclinical Drug Development Services Segment by Application in 2022
Figure 3. Global Preclinical Drug Development Services Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Preclinical Drug Development Services Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Preclinical Drug Development Services Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Preclinical Drug Development Services Revenue in 2022
Figure 8. By Type - Global Preclinical Drug Development Services Revenue Market Share, 2018-2029
Figure 9. By Application - Global Preclinical Drug Development Services Revenue Market Share, 2018-2029
Figure 10. By Type - Global Preclinical Drug Development Services Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Preclinical Drug Development Services Revenue Market Share, 2018-2029
Figure 12. By Application - Global Preclinical Drug Development Services Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Preclinical Drug Development Services Revenue Market Share, 2018-2029
Figure 14. By Region - Global Preclinical Drug Development Services Revenue Market Share, 2018-2029
Figure 15. By Country - North America Preclinical Drug Development Services Revenue Market Share, 2018-2029
Figure 16. US Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Preclinical Drug Development Services Revenue Market Share, 2018-2029
Figure 20. Germany Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 21. France Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Preclinical Drug Development Services Revenue Market Share, 2018-2029
Figure 28. China Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 32. India Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Preclinical Drug Development Services Revenue Market Share, 2018-2029
Figure 34. Brazil Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Preclinical Drug Development Services Revenue Market Share, 2018-2029
Figure 37. Turkey Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Preclinical Drug Development Services Revenue, (US$, Mn), 2018-2029
Figure 41. Wuxi AppTec Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Labcorp Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Charles River Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Eurofins Scientific Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. PPD, Inc. Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. ICON Plc. Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Pharmaron Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Inotiv Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. ChemPartner Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. JOINN Lab Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. EVOTEC Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Medicilon Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Noble Life Sciences Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
